BEAM Beam Therapeutics Inc

$22.21

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Beam Therapeutics, with its market cap of approximately $2.5 billion, is poised for its upcoming earnings report on November 10, 2025, amid a backdrop of anticipation surrounding its innovative gene-editing technologies. Despite the absence of recent news, the company's strategic focus on precision genetic medicine continues to capture investor interest. Analysts are forecasting an EPS of $0.00, aligning with the whisper number, and projecting revenues of $11.34 million. This revenue estimate reflects Beam's ongoing efforts to transition its groundbreaking research into viable commercial products. As the market awaits further developments, the alignment of the EPS estimate with the whisper number suggests a cautious optimism, with investors keenly watching for any strategic updates that could signal future growth trajectories.

Updated On 11/21/2025

About Beam Therapeutics Inc

Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. The company is headquartered in Cambridge, Massachusetts.

Website: https://beamtx.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1745999
Address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, US
Valuation
Market Cap
$1.70B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
2.31
Performance
EPS
$-4.58
Dividend Yield
—
Profit Margin
0.00%
ROE
-43.90%
Technicals
50D MA
$23.91
200D MA
$25.24
52W High
$35.25
52W Low
$13.53
Fundamentals
Shares Outstanding
100M
Target Price
$49.00
Beta
2.02

BEAM EPS Estimates vs Actual

● Estimated
● Actual

BEAM News & Sentiment

Nov 21, 2025 • Zacks Commentary NEUTRAL
NTLA Declines 67% in a Month: Should You Buy, Sell or Hold the Stock?
Intellia sinks 67% in a month after a clinical hold on nex-z and mixed third-quarter results, raising questions about its pipeline outlook and near-term direction.
Nov 18, 2025 • Benzinga SOMEWHAT-BULLISH
Cathie Wood Bets Big On This Peter Thiel-Backed Coinbase Rival As Bitcoin Crashes Below $91,000 - Grayscale Bitcoin Mini Trust ( BTC ) Common units of fractional undivided beneficial interest ( ARCA:BTC )
On Monday, Cathie Wood-led Ark Invest executed significant trades involving Bullish ( NYSE:BLSH ) , Reddit Inc. ( NYSE:RDDT ) , and Pinterest Inc. ( NYSE:PINS ) .
Nov 14, 2025 • Zacks Commentary NEUTRAL
Can NTLA Stock Bounce Back in 2026 After Recent Pipeline Setbacks?
Intellia faces FDA clinical holds on key ATTR studies as it readies crucial HAE data in 2026, making lonvo-z pivotal for its near-term outlook.
Nov 14, 2025 • Benzinga SOMEWHAT-BULLISH
Cathie Dumps AMD And Reddit Shares Amid Tech Bloodbath, Ark Doubles Down On Tom Lee And Peter Thiel Crypto Plays - Advanced Micro Devices ( NASDAQ:AMD )
On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably involving Circle Internet Group Inc ( NYSE:CRCL ) , Bitmine Immersion Technologies Inc ( NYSE:BMNR ) , Bullish ( NYSE:BLSH ) , Advanced Micro Devices Inc ( NASDAQ:AMD ) , and Reddit Inc ( NYSE:RDDT ) .
Nov 12, 2025 • Benzinga SOMEWHAT-BULLISH
Beam Therapeutics to Participate in 2025 Jefferies London Healthcare Conference - Beam Therapeutics ( NASDAQ:BEAM )
CAMBRIDGE, Mass., Nov. 12, 2025 ( GLOBE NEWSWIRE ) -- Beam Therapeutics Inc. ( NASDAQ:BEAM ) , a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in a fireside chat during the 2025 Jefferies London Healthcare ...
Nov 11, 2025 • Benzinga BULLISH
Cathie Wood Dumps $2.4 Million Worth Of Tesla Stock, Doubles Down On These AI Stocks - Tesla ( NASDAQ:TSLA )
On Monday, Cathie Wood-led Ark Invest executed significant trades involving Tesla Inc. ( NASDAQ:TSLA ) , Pony AI Inc. ( NASDAQ:PONY ) , Taiwan Semiconductor Manufacturing Co. Ltd. ( NYSE:TSM ) , and Baidu Inc. ( NASDAQ:BIDU ) . These trades highlight Ark's strategic positioning in the tech and AI ...
Sentiment Snapshot

Average Sentiment Score:

0.171
50 articles with scored sentiment

Overall Sentiment:

Bullish

BEAM Reported Earnings

Aug 05, 2025
Jun 30, 2025 (Pre market)
0.11 Surprise
  • Reported EPS: $-1.00
  • Estimate: $-1.11
  • Whisper: —
  • Surprise %: 9.9%
May 06, 2025
Mar 31, 2025 (Pre market)
-0.07 Surprise
  • Reported EPS: $-1.24
  • Estimate: $-1.17
  • Whisper: —
  • Surprise %: -6.0%
Feb 25, 2025
Dec 31, 2024 (Pre market)
0.13 Surprise
  • Reported EPS: $-1.09
  • Estimate: $-1.22
  • Whisper: —
  • Surprise %: 10.3%
Nov 05, 2024
Sep 30, 2024 (Pre market)
-0.01 Surprise
  • Reported EPS: $-1.17
  • Estimate: $-1.16
  • Whisper: —
  • Surprise %: -0.9%
Aug 06, 2024
Jun 30, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $-1.11
  • Estimate: $-1.13
  • Whisper: —
  • Surprise %: 1.8%
May 07, 2024
Mar 31, 2024 (Pre market)
0.21 Surprise
  • Reported EPS: $-1.21
  • Estimate: $-1.42
  • Whisper: —
  • Surprise %: 14.8%
Feb 27, 2024
Dec 31, 2023 (Pre market)
2.74 Surprise
  • Reported EPS: $1.73
  • Estimate: $-1.01
  • Whisper: —
  • Surprise %: 271.3%
Nov 08, 2023
Sep 30, 2023 (Pre market)
0.14 Surprise
  • Reported EPS: $-1.22
  • Estimate: $-1.36
  • Whisper: —
  • Surprise %: 10.3%
Aug 08, 2023
Jun 30, 2023 (Pre market)
0.34 Surprise
  • Reported EPS: $-1.08
  • Estimate: $-1.42
  • Whisper: —
  • Surprise %: 23.9%

Financials